Pediatrics Doctors in Brewer, ME Accepting Medicare

7 Pediatrics doctors found. Showing 1 - 7

Dr. Hardeo Karamchand Panchoosingh, MD Pediatrics - Pediatric Hematology-Oncology Medicare: Medicare Enrolled Practice Location: 33 Whiting Hill Rd, Brewer, ME 04412 Phone: 207-973-7572

Nadine Patricia Sauer Santacruz, M.D. Pediatrics - Pediatric Hematology-Oncology Medicare: Accepting Medicare Assignments Practice Location: 33 Whiting Hill Rd, Suite 31, Brewer, ME 04412 Phone: 207-973-7572

Dr. Daniel Lee Callaway, M.D. Pediatrics - Pediatric Hematology-Oncology Medicare: Accepting Medicare Assignments Practice Location: 33 Whiting Hill Rd, Brewer, ME 04412 Phone: 207-973-9733

Dr. Sarah J Fryberger, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 33 Whiting Hill Rd, Suite 31, Brewer, ME 04412 Phone: 207-973-7572    Fax: 207-973-7589

Chittalsinh M. Raulji, MD Pediatrics - Pediatric Hematology-Oncology Medicare: Medicare Enrolled Practice Location: 33 Whiting Hill Rd, Suite 31, Brewer, ME 04412 Phone: 207-973-7572

Albert W Adams, MD Pediatrics Medicare: May Accept Medicare Assignments Practice Location: 399 S Main St, Brewer, ME 04412 Phone: 207-989-9821    Fax: 207-989-9822

Subha Mazzone, M.D. Pediatrics - Pediatric Hematology-Oncology Medicare: Medicare Enrolled Practice Location: 33 Whiting Hill Rd, Suite 31, Brewer, ME 04412 Phone: 207-973-7478

News Archive

Ninth Circuit rules in favor of ACLJ in multi-million dollar fraud case against Planned Parenthood affiliates

The United States Court of Appeals for the Ninth Circuit has ruled in favor of the American Center for Law and Justice's (ACLJ) client in a multi-million dollar fraud case against Planned Parenthood (PP) affiliates in California. ACLJ attorneys are representing a former employee of the PP affiliate in Los Angeles, who is now a federal whistleblower. A federal district court in California had dismissed the case, but the Ninth Circuit's ruling, dated yesterday, reinstates the lawsuit.

Shire to commence two Vyvanse and Concerta Phase 4 comparison trials for ADHD

As part of its continued commitment to ADHD research, Shire plc, the global specialty biopharmaceutical company, today announced it is initiating two Phase 4 clinical trials to compare Vyvanse (lisdexamfetamine dimesylate) Capsules, (CII) to Concerta (methylphenidate HCl) Extended-Release Tablets.

Viewpoints: Health law still facing major challenges; Ky. gov. questions McConnell's assessment of overhaul; Pa.'s Medicaid experiment is a 'sham'

The White House is claiming that the Healthcare.gov website is mostly fixed, that the millions of Americans whose health plans were canceled thanks to government rules may be able to keep them for another year, and that in any event these people will get better plans through ObamaCare exchanges. Whatever the truth of these assertions, those who expect better days ahead for the Affordable Care Act are in for a rude awakening. The shocks-;economic and political-;will get much worse next year and beyond (Michael J. Boskin, 12/15).

NEJM releases findings about behavioral impact of personal genetic testing

Navigenics, a leading personal genomics company, announced today that The New England Journal of Medicine has published findings from the Scripps Genomic Health Initiative, a research study sponsored by Scripps Translational Science Institute to assess the behavioral impact of personal genetic testing.

Cellectis, Medicago complete first step in therapeutic protein research collaboration

Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus Like Particles, and Cellectis plant sciences, a US-based subsidiary of Cellectis Group, the specialist in genome engineering, today announced the successful completion of the first step in their research collaboration to improve therapeutic proteins produced in tobacco plants.

Read more Medical News

› Verified 4 days ago